New cell therapy shows promise for Late-Stomach cancer patients
NCT ID NCT07212933
Summary
This study tests a new treatment called RAK cell therapy for people with advanced stomach cancer that has spread or come back after standard treatment. The therapy uses immune cells from donated umbilical cord blood to fight the cancer. Researchers will check if it helps patients live longer without their cancer growing, and monitor any side effects. The study involves 90 adults aged 18 to 70.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First＆Fifth Medical Center of Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, 100853, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.